36 citations
- AbbVie (Germany)DE1 paper
- Berry & Associates (United States)US1 paper
- Biogen (United States)US1 paper
- Boehringer Ingelheim (Germany)DE1 paper
- Fred Hutch Cancer CenterUS1 paper
- GlaxoSmithKline (United States)US1 paper
- Google (United States)US1 paper
- Janssen Research & Development (United States)US1 paper
- Massachusetts Institute of TechnologyUS1 paper
- Medical University of ViennaAT1 paper
- Merck & Co., Inc., Rahway, NJ, USA (United States)US1 paper
- Michigan State UniversityUS1 paper
Showing 2021 · cs.CLShow all
2 papers · 2 filters
cs.CL2021
NADE: A Benchmark for Robust Adverse Drug Events Extraction in Face of Negations
Simone Scaboro, Beatrice Portelli, Emmanuele Chersoni +2
Adverse Drug Event (ADE) extraction models can rapidly examine large collections of social media texts, detecting mentions of drug-related adverse reactions and trigger medical inv…
cs.CL2021
Exploring a Unified Sequence-To-Sequence Transformer for Medical Product Safety Monitoring in Social Media
Shivam Raval, Hooman Sedghamiz, Enrico Santus +3
Adverse Events (AE) are harmful events resulting from the use of medical products. Although social media may be crucial for early AE detection, the sheer scale of this data makes i…